Troponin Testing and Coronary Syndrome in Geriatric Patients With Nonspecific Complaints: Are We Overtesting?
- PMID: 31854117
- DOI: 10.1111/acem.13766
Troponin Testing and Coronary Syndrome in Geriatric Patients With Nonspecific Complaints: Are We Overtesting?
Abstract
Background: Elderly patients presenting to the emergency department (ED) with nonspecific complaints (NSCs) often undergo troponin testing to assess for atypical acute coronary syndrome (ACS). However, the rate of ACS and utility of troponin testing in this population is unknown. We sought to determine the rate of ACS and diagnostic yield of troponin testing in elderly patients with NSCs.
Methods: We retrospectively identified all patients aged ≥ 65 years triaged in the ED with NSCs from January 1, 2017, to June 30, 2017. NSCs were defined a priori and included complaints such as weakness, dizziness, or fatigue. NSCs were verified in ED provider notes by trained abstractors blind to testing results. Exclusions were focal chief complaint in provider notes, fever, and no troponin ordered. ACS was strictly defined and independently adjudicated by two trained physician researchers blind to the study hypothesis. We calculated the proportion of patients with ACS within 30 days and the test characteristics of troponin to diagnose ACS.
Results: Screening identified 1,146 encounters, and 552 were excluded for fever or focal chief complaints in the provider notes. Of the remaining 594 patients, troponin was ordered in 412 (69%), comprising the study cohort. The mean (±SD) age was 78.7 (±8.3) years, with 58% female and 75% admitted. Troponin elevation occurred in 81 patients (20%). ACS occurred in 5 of 412 (1.2%). Troponin was 100% sensitive (95% confidence interval [CI] = 48% to 100%) and 81% specific (95% CI = 77% to 85%) for ACS. Of patients with elevated troponin, 93.8% were false positives (no ACS). All patients with troponin elevation were admitted, but only one underwent angiography and no patients received reperfusion therapy.
Conclusions: While consideration for ACS is prudent in selected elderly patients with NSCs, ACS was rare and no patients received reperfusion therapy. Given the false-positive rate in our study, our results may not support routine troponin testing for ACS in this population.
© 2019 by the Society for Academic Emergency Medicine.
Comment in
-
In Reply.Acad Emerg Med. 2020 Jul;27(7):646-647. doi: 10.1111/acem.13996. Epub 2020 May 28. Acad Emerg Med. 2020. PMID: 32329954 No abstract available.
-
Second Look: The Predictive Value of Elevated Cardiac Troponins Often Depends on Retesting.Acad Emerg Med. 2020 Jul;27(7):644-645. doi: 10.1111/acem.14011. Epub 2020 Jun 23. Acad Emerg Med. 2020. PMID: 32412107 No abstract available.
References
-
- National Hospital Ambulatory Medical Care Survey: 2010 Emergency Department Summary Tables. Atlanta: Centers for Disease Control and Prevention; 2011.
-
- Hustey FM, Mion LC, Connor JT, Emerman CL, Campbell J, Palmer RM. A brief risk stratification tool to predict functional decline in older adults discharged from emergency departments. J Am Geriatr Soc 2007;55:1269-74.
-
- Wachelder JJ. Elderly emergency patients presenting with non-specific complaints: characteristics and outcomes. PLoS One 2017;12:e0188954.
-
- McCusker J, Verdon J, Tousignant P, de Courval LP, Dendukuri N, Belzile E. Rapid emergency department intervention for older people reduces risk of functional decline: results of a multicenter randomized trial. J Am Geriatr Soc 2001;49:1272-81.
-
- Provencher V, Sirois MJ, Ouellet MC, et al. Decline in activities of daily living after a visit to a Canadian emergency department for minor injuries in independent older adults: are frail older adults with cognitive impairment at greater risk? J Am Geriatr Soc 2015;63:860-8.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources